Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease: an Open Label, a Cluster Randomized Controlled, Phase 3 Trial

NCT05732727 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT05732727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease: an Open Label, a Cluster Randomized Controlled, Phase 3 Trial
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Recruiting
Start date
March 28, 2023
Completion date
March 31, 2029
Enrollment
720 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease(ckd), uncontrolled hypertension